title: Biologics in systemic lupus erythematosus: current options and future perspectives.
abstract: Data from clinical trials highlighted the potential and pitfalls of the use of biologics to treat systemic lupus erythematosus. With improved understanding of immunopathogenesis and lessons learned from controlled trials, there is a growing optimism for personalized treatment from an increasing range of targeted therapies.
authors.affiliation: NIHR Academic Clinical Fellow and Specialist Registrar in Rheumatology.
authors.forename: Md Yuzaiful
authors.initials: MY
authors.lastname: Md Yusof
authors.forename: Edward M
authors.initials: EM
authors.lastname: Vital
authors.forename: Paul
authors.initials: P
authors.lastname: Emery
mesh_terms: D001688:Biological Products / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D058990:Molecular Targeted Therapy
chemical_list: D001688:Biological Products; D007155:Immunologic Factors